AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2177648 — intervention group
Group type: EXPERIMENTAL
Intervention: Dydrogesterone 10 mg/day in reverse sequence
Number of subjects: 16
Study 2177648 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dydrogesterone doses
Number of subjects: 16
Study 375858 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-mg troche, five times a day for two weeks
Number of subjects: 0
Study 375858 — intervention group
Group type: EXPERIMENTAL
Intervention: 50-mg troche, five times a day for two weeks
Number of subjects: 0
Study 30593775 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA CE 0.1% (1 mg/ml) eye drops 4 times daily (high dose)
Number of subjects: 169
Study 30593775 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA CE twice daily (low dose) plus vehicle twice daily
Number of subjects: 169
Study 30593775 — intervention group
Group type: COMPARATOR
Intervention: Vehicle 4 times daily
Number of subjects: 169
Study 30593775 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose CsA CE
Number of subjects: 169
Study 30593775 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CsA CE
Number of subjects: 169
Study 27876603 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) - 48 Gy in 4 fractions for peripherally located lesions; 60 Gy in 8 fractions for centrally located lesions
Number of subjects: 324
Study 27876603 — intervention group
Group type: COMPARATOR
Intervention: Conventionally hypofractionated radiotherapy (CRT) - 60 Gy in 15 fractions
Number of subjects: 324
Study 27876603 — intervention group
Group type: EXPERIMENTAL
Intervention: SBRT
Number of subjects: 324
Study 26329614 — intervention group
Group type: EXPERIMENTAL
Intervention: CHAP intervention (community-based program)
Number of subjects: 0
Study 26329614 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 23154219 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooking television program
Number of subjects: 80
Study 23154219 — intervention group
Group type: COMPARATOR
Intervention: Nature television program
Number of subjects: 80
Study 22014247 — intervention group
Group type: EXPERIMENTAL
Intervention: Pocket guide
Number of subjects: 115
Study 22014247 — intervention group
Group type: COMPARATOR
Intervention: UpToDate
Number of subjects: 115
Study 19080457 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-point puncture group
Number of subjects: 94
Study 19080457 — intervention group
Group type: COMPARATOR
Intervention: One-point puncture group
Number of subjects: 94
Study 16825000 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild TR
Number of subjects: 225
Study 16825000 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate TR
Number of subjects: 225
Study 16825000 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe TR
Number of subjects: 225
Study 16167722 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol (250 mcg every four hours)
Number of subjects: 121
Study 16167722 — intervention group
Group type: COMPARATOR
Intervention: Intracervical Foley's catheter
Number of subjects: 121
Study 10708161 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (0.15 mg rhGH/kg/day)
Number of subjects: 28
Study 10708161 — intervention group
Group type: COMPARATOR
Intervention: Total parenteral nutrition alone
Number of subjects: 28
Study 10708161 — intervention group
Group type: COMPARATOR
Intervention: Normal postabsorptive controls
Number of subjects: 28
Study 9396090 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate ointment (2%)
Number of subjects: 10
Study 9396090 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinic acid ointment (10%)
Number of subjects: 10
Study 9396090 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 10
Study 8135384 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 microgram/kg of clonidine (CG)
Number of subjects: 45
Study 8135384 — intervention group
Group type: COMPARATOR
Intervention: Epinephrine 1/200,000 (EG)
Number of subjects: 45
Study 8135384 — intervention group
Group type: COMPARATOR
Intervention: No additional medication (BG)
Number of subjects: 45
Study 2680795 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) 240 mg twice daily
Number of subjects: 50
Study 2680795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 2680795 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) after an additional course
Number of subjects: 50
Study 2680795 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) and Placebo
Number of subjects: 50
Study 797554 — intervention group
Group type: EXPERIMENTAL
Intervention: Desonide cream
Number of subjects: 100
Study 797554 — intervention group
Group type: COMPARATOR
Intervention: Fluocinonide cream
Number of subjects: 100
Study 31053405 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin (50 mg/m2) and Doxorubicin (45 mg/m2)
Number of subjects: 311
Study 31053405 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (50 mg/m2), Doxorubicin (45 mg/m2), and Paclitaxel (160 mg/m2)
Number of subjects: 311
Study 27931762 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal ketamine 1 mg/kg
Number of subjects: 40
Study 27931762 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine 0.1 mg/kg
Number of subjects: 40
Study 25080875 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary treatment (combining pharmacological treatment, education, physical therapy, and cognitive behavioural therapy)
Number of subjects: 130
Study 25080875 — intervention group
Group type: COMPARATOR
Intervention: Conventional pharmacologic treatment
Number of subjects: 130
Study 25458645 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive cardiac rehabilitation (CR) including exercise training (ET) for 6 months, biweekly sessions, endurance and low-intensity resistance training.
Number of subjects: 0
Study 25458645 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) with management according to current heart failure guidelines.
Number of subjects: 0
Study 25458645 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive cardiac rehabilitation (CR) including exercise training (ET) for 6 months.
Number of subjects: 0
Study 22973911 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous endoscopic gastrostomy (PEG)
Number of subjects: 0
Study 22973911 — intervention group
Group type: COMPARATOR
Intervention: Nasogastric tube (NGT)
Number of subjects: 0
Study 22973911 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG
Number of subjects: 0
Study 22973911 — intervention group
Group type: COMPARATOR
Intervention: NGT
Number of subjects: 0
Study 19201326 — intervention group
Group type: EXPERIMENTAL
Intervention: HFLCS (Pro Seal, Reliance Orthodontic Products, Itasca, Ill) applied to etched enamel surfaces before bonding.
Number of subjects: 80
Study 19201326 — intervention group
Group type: COMPARATOR
Intervention: No HFLCS applied (control group) with brackets bonded directly to etched enamel surfaces.
Number of subjects: 80
Study 19201326 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal brackets bonded with RMGIC.
Number of subjects: 80
Study 19201326 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic brackets bonded with RMGIC.
Number of subjects: 80
Study 17542406 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucocyte-depleted (LD) isothermic blood cardioplegia
Number of subjects: 0
Study 17542406 — intervention group
Group type: COMPARATOR
Intervention: Isothermic blood cardioplegia (Control)
Number of subjects: 0
Study 15198764 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored multifaceted strategy (audit and feedback, educational meetings, structured case records, patient information booklet)
Number of subjects: 26
Study 15198764 — intervention group
Group type: COMPARATOR
Intervention: Printed guideline summaries
Number of subjects: 26
Study 11487606 — intervention group
Group type: EXPERIMENTAL
Intervention: Skilled finger movement exercise
Number of subjects: 14
Study 9183581 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable angina pectoris patients
Number of subjects: 767
Study 9183581 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 767
Study 9183581 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients with stable angina pectoris
Number of subjects: 767
Study 9183581 — intervention group
Group type: EXPERIMENTAL
Intervention: Male patients with stable angina pectoris
Number of subjects: 767
Study 1397477 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezafibrate (BZF) 400 mg/day for one month
Number of subjects: 16
Study 1397477 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox (APX) 500 mg/day for one month
Number of subjects: 16
Study 3554901 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam (10 mg nocte)
Number of subjects: 12
Study 3554901 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam (20 mg nocte)
Number of subjects: 12
Study 3554901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30154027 — intervention group
Group type: EXPERIMENTAL
Intervention: MONEO platform (smartphone-based), cognitive training twice a week, assessed monthly via teleconference
Number of subjects: 290
Study 30154027 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (limited functionality, cognitive training every 6 months)
Number of subjects: 290
Study 30154027 — intervention group
Group type: EXPERIMENTAL
Intervention: MONEO platform (study group)
Number of subjects: 290
Study 30154027 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 290
Study 29864505 — intervention group
Group type: EXPERIMENTAL
Intervention: Inorganic NO3- supplementation (beetroot powder; 250 mg of NO3- and 20 mg of NO2-) for four weeks
Number of subjects: 13
Study 29864505 — intervention group
Group type: COMPARATOR
Intervention: Placebo (beetroot powder devoid of NO3-/NO2-) for four weeks
Number of subjects: 13
Study 26670174 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR-guided PCI
Number of subjects: 1157
Study 26670174 — intervention group
Group type: COMPARATOR
Intervention: Angio-guided PCI
Number of subjects: 1157
Study 24769563 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan mouthrinse
Number of subjects: 80
Study 24769563 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline (control)
Number of subjects: 80
Study 24769563 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthrinse
Number of subjects: 80
Study 24769563 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential oils in ethanolic solution mouthrinse
Number of subjects: 80
Study 23232161 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training combined with Conventional Therapy (CT)
Number of subjects: 26
Study 23232161 — intervention group
Group type: COMPARATOR
Intervention: Conventional Therapy (CT)
Number of subjects: 26
Study 23232161 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (VR + CT and CT)
Number of subjects: 26
Study 19937975 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic resection
Number of subjects: 326
Study 19937975 — intervention group
Group type: COMPARATOR
Intervention: Open resection
Number of subjects: 326
Study 17491269 — intervention group
Group type: EXPERIMENTAL
Intervention: Longqingpian combined with Levofloxacin
Number of subjects: 80
Study 17491269 — intervention group
Group type: COMPARATOR
Intervention: Puleanpian combined with Levofloxacin
Number of subjects: 80
Study 15840746 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg twice daily)
Number of subjects: 100
Study 15840746 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate (150 mg for 5 days from the third day of a progesterone withdrawal bleeding)
Number of subjects: 100
Study 12477504 — intervention group
Group type: EXPERIMENTAL
Intervention: IV albumin treatment for OHSS
Number of subjects: 43
Study 12477504 — intervention group
Group type: COMPARATOR
Intervention: Normal control women
Number of subjects: 43
Study 12477504 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with OHSS before treatment
Number of subjects: 43
Study 9790269 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP-144SR (long-acting gonadotropin-releasing hormone analog)
Number of subjects: 35
Study 7621492 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.55 mM CHX plus NaF
Number of subjects: 10
Study 7621492 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.2 mM CHX plus NaF
Number of subjects: 10
Study 7621492 — intervention group
Group type: COMPARATOR
Intervention: 12.0 mM NaF
Number of subjects: 10
Study 2279371 — intervention group
Group type: EXPERIMENTAL
Intervention: Corometrics and Cetro single spiral electrodes
Number of subjects: 50
Study 2279371 — intervention group
Group type: EXPERIMENTAL
Intervention: Hewlett-Packard double spiral electrode
Number of subjects: 50
Study 2279371 — intervention group
Group type: EXPERIMENTAL
Intervention: Copeland electrodes
Number of subjects: 50
Study 7412428 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow-sheet summary record (Group S)
Number of subjects: 95
Study 7412428 — intervention group
Group type: COMPARATOR
Intervention: Standard medical record plus flow-sheet summary record (Group C)
Number of subjects: 95
Study 29239982 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Set (TS)
Number of subjects: 13
Study 29239982 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired Set (PS)
Number of subjects: 13
Study 29239982 — intervention group
Group type: EXPERIMENTAL
Intervention: Superset (SS)
Number of subjects: 13
Study 28731609 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary sodium intake (mean Na intake: 4309.6 ± 1344.4 mg/day)
Number of subjects: 796
Study 28731609 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary sodium/potassium (Na/K) ratio
Number of subjects: 796
Study 28731609 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary sodium/potassium (UNa/UK) ratio
Number of subjects: 796
Study 25434837 — intervention group
Group type: EXPERIMENTAL
Intervention: FOS group (subjective assessment of force of stream)
Number of subjects: 108
Study 25434837 — intervention group
Group type: COMPARATOR
Intervention: SVT group (standard voiding trial)
Number of subjects: 108
Study 25434837 — intervention group
Group type: EXPERIMENTAL
Intervention: FOS group
Number of subjects: 108
Study 25434837 — intervention group
Group type: COMPARATOR
Intervention: SVT group
Number of subjects: 108
Study 25434837 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (FOS and SVT)
Number of subjects: 108
Study 22762449 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine case management (televideo educator visits, individualized goal-setting/problem solving)
Number of subjects: 1665
Study 22762449 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1665
Study 22762449 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine case management
Number of subjects: 1665
Study 21292644 — intervention group
Group type: COMPARATOR
Intervention: Pegfilgrastim on day 2
Number of subjects: 103
Study 21292644 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegfilgrastim on day 4
Number of subjects: 103
Study 19627212 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey solution (75 g once daily for 14 days)
Number of subjects: 60
Study 19627212 — intervention group
Group type: COMPARATOR
Intervention: Sugar solution (honey-comparable, 75 g once daily for 14 days)
Number of subjects: 60
Study 17846668 — intervention group
Group type: EXPERIMENTAL
Intervention: ABM/P‐15 'putty' graft group
Number of subjects: 16
Study 17846668 — intervention group
Group type: COMPARATOR
Intervention: OFD (Open Flap Debridement)
Number of subjects: 16
Study 15586631 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG PET in generalized epilepsy
Number of subjects: 22
Study 15586631 — intervention group
Group type: COMPARATOR
Intervention: FDG PET in localization related epilepsy
Number of subjects: 22
Study 11565668 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocapnia (PaCO2 = 30 to 32 mm Hg)
Number of subjects: 61
Study 11565668 — intervention group
Group type: COMPARATOR
Intervention: Normocapnia (PaCO2 = 40 to 42 mm Hg)
Number of subjects: 61
Study 9632446 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated irradiation plus concurrent chemotherapy (combined treatment)
Number of subjects: 116
Study 9632446 — intervention group
Group type: COMPARATOR
Intervention: Hyperfractionated irradiation alone
Number of subjects: 116
Study 8148291 — intervention group
Group type: EXPERIMENTAL
Intervention: Subarachnoid morphine sulfate 0.25 mg and fentanyl 25 micrograms via CSE technique
Number of subjects: 59
Study 8148291 — intervention group
Group type: COMPARATOR
Intervention: Conventional epidural analgesia
Number of subjects: 59
Study 3339839 — intervention group
Group type: COMPARATOR
Intervention: HMO
Number of subjects: 244
Study 3339839 — intervention group
Group type: EXPERIMENTAL
Intervention: free-for-service care
Number of subjects: 244
Study 31715440 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic pain status
Number of subjects: 309
Study 31715440 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic pain prevalence
Number of subjects: 309
Study 31715440 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic pain and opioid use
Number of subjects: 309
Study 28697492 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 354
Study 25130918 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper oxide impregnated socks
Number of subjects: 60
Study 25130918 — intervention group
Group type: COMPARATOR
Intervention: Control socks (without copper oxide)
Number of subjects: 60
Study 23222083 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Number of subjects: 7
Study 23222083 — intervention group
Group type: COMPARATOR
Intervention: Traditional ergometer rowing training
Number of subjects: 7
Study 20886729 — intervention group
Group type: EXPERIMENTAL
Intervention: Administration of immunomodulators
Number of subjects: 0
Study 18181711 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 0
Study 18181711 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 15905656 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-aided dosing of warfarin (n=14)
Number of subjects: 30
Study 15905656 — intervention group
Group type: COMPARATOR
Intervention: Clinician dosing of warfarin (n=16)
Number of subjects: 30
Study 13129806 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole 100 mg daily
Number of subjects: 1282
Study 13129806 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1282
Study 10741628 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/day oral mibefradil for 8 days
Number of subjects: 10
Study 10741628 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg/day oral mibefradil for 8 days
Number of subjects: 10
Study 9023498 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine acetylsalicylate 1.8 g
Number of subjects: 150
Study 9023498 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 100 mg
Number of subjects: 150
Study 9023498 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine 100 mg
Number of subjects: 150
Study 1353717 — intervention group
Group type: EXPERIMENTAL
Intervention: salbutamol 5 mg
Number of subjects: 24
Study 1353717 — intervention group
Group type: EXPERIMENTAL
Intervention: fenoterol 5 mg
Number of subjects: 24
Study 1353717 — intervention group
Group type: COMPARATOR
Intervention: normal saline solution
Number of subjects: 24
Study 6342295 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally injected orgotein
Number of subjects: 0
Study 6342295 — intervention group
Group type: COMPARATOR
Intervention: Injection with procaine hydrochloride (control)
Number of subjects: 0
Study 31771512 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep cervical block (DCB) receiving 20 mL ropivacaine 0.5% (n=10)
Number of subjects: 30
Study 31771512 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate cervical block (ICB) receiving 20 mL ropivacaine 0.5% (n=10)
Number of subjects: 30
Study 31771512 — intervention group
Group type: EXPERIMENTAL
Intervention: Perivascular infiltration of the internal carotid artery (PVB) receiving 20 mL ropivacaine 0.5% and 10 mL ropivacaine 0.3% (n=10)
Number of subjects: 30
Study 26801970 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention (EI) service for psychosis (EASY) in adults, collected from 2009 to 2011.
Number of subjects: 0
Study 26801970 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention (EI) service for psychosis (EASY) in youth, collected in 2010.
Number of subjects: 0
Study 26801970 — intervention group
Group type: COMPARATOR
Intervention: Control group (FEP study 1 year before the EI service, 2000) for adults.
Number of subjects: 0
Study 26801970 — intervention group
Group type: COMPARATOR
Intervention: Control group (FEP study 1 year before the EI service, 2000) for youth.
Number of subjects: 0
Study 26362785 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative decolonization treatment for S aureus carriers
Number of subjects: 1028
Study 26362785 — intervention group
Group type: COMPARATOR
Intervention: Noncarriers (no treatment)
Number of subjects: 1028
Study 26362785 — intervention group
Group type: EXPERIMENTAL
Intervention: S aureus carriers
Number of subjects: 1028
Study 25495568 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide and standard-dosed Solifenacin (10 mg per day)
Number of subjects: 378
Study 25495568 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide and low-dosed Solifenacin (5 mg per day)
Number of subjects: 378
Study 25495568 — intervention group
Group type: COMPARATOR
Intervention: Furosemide only (Control group)
Number of subjects: 378
Study 22521671 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative ibuprofen (600 mg p.o. 1h before surgery)
Number of subjects: 120
Study 22521671 — intervention group
Group type: COMPARATOR
Intervention: Postoperative ibuprofen (placebo after surgery)
Number of subjects: 120
Study 20141734 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp penetration acupuncture
Number of subjects: 70
Study 20141734 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 70
Study 17695436 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative chemotherapy
Number of subjects: 180
Study 17695436 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 180